Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine or Tramadol Added to Paracetamol for Catheter-Related Bladder Discomfort in PCNL
NCT06274333Phase 3Recruiting
- Sponsor
- Al-Azhar University
- Start
- Feb 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine and tramadol in cystitis (2 arms), sponsored by Al-Azhar University. Primary endpoint: Incidence of Catheter-Related Bladder Discomfort at 24 hours. Started Feb 2024; status: recruiting.
02
Drugs
dexmedetomidinetramadol
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT06274333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06274333.